BIOSIG TECHNOLOGIES INC's ticker is BSGM and the CUSIP is 09073N201. A total of 54 filers reported holding BIOSIG TECHNOLOGIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $5,638 | -2.9% | 11,870 | 0.0% | 0.00% | – |
| Q3 2023 | $5,807 | -60.9% | 11,870 | 0.0% | 0.00% | – |
| Q2 2023 | $14,838 | +9.7% | 11,870 | 0.0% | 0.00% | – |
| Q1 2023 | $13,532 | +270540.0% | 11,870 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 11,870 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 11,870 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -42.9% | 11,870 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -46.2% | 11,870 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -29.7% | 11,870 | -3.7% | 0.00% | – |
| Q3 2021 | $37,000 | -22.9% | 12,320 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | -9.4% | 12,320 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $53,000 | +10.4% | 12,320 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $48,000 | -14.3% | 12,320 | +8.8% | 0.00% | 0.0% |
| Q3 2020 | $56,000 | -22.2% | 11,320 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $72,000 | -6.5% | 10,000 | -23.1% | 0.00% | 0.0% |
| Q4 2019 | $77,000 | -7.2% | 13,000 | +30.0% | 0.00% | 0.0% |
| Q3 2019 | $83,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 100,891 | $434,840,000 | 0.50% |
| Saltoro Capital, LP | 175,423 | $756,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 103,392 | $446,000 | 0.07% |
| ZEKE CAPITAL ADVISORS, LLC | 151,629 | $654,000 | 0.05% |
| Cornerstone Wealth Group, LLC | 60,000 | $209,000 | 0.04% |
| Granite Investment Advisors, LLC | 56,600 | $244,000 | 0.04% |
| Bridgewater Advisors Inc. | 17,300 | $53,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 14,652 | $63,000 | 0.01% |
| Sargent Investment Group, LLC | 10,000 | $43,000 | 0.01% |
| TRANSCEND CAPITAL ADVISORS, LLC | 16,250 | $70,000 | 0.01% |